Iguratimod Inhibits the Aggressiveness of Rheumatoid Fibroblast-Like Synoviocytes

OBJECTIVE: Iguratimod, a novel disease-modifying anti-rheumatic drug for the treatment of rheumatoid arthritis, has been approved in China and Japan. Here, we aimed to find whether iguratimod can inhibit the aggressive behavior and promote apoptosis of rheumatoid fibroblast-like synoviocytes (RA-FLS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunol Res
Main Authors: Lin, Jin, Yu, Ye, Wang, Xuanwei, Ke, Yini, Sun, Chuanyin, Yue, Lihuan, Xu, Guanhua, Xu, Bei, Xu, Liqin, Cao, Heng, Xu, Danyi, Olsen, Nancy, Chen, Weiqian
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6885276/
https://ncbi.nlm.nih.gov/pubmed/31828173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/6929286
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados